Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Rezdiffra
Rezdiffra
Madrigal’s MASH drug sales again top Wall Street projections
BioPharma Dive
Thu, 05/1/25 - 10:13 pm
Madrigal Pharmaceuticals
Rezdiffra
earnings
MASH
Launch metrics of Madrigal's MASH drug Rezdiffra track 'exceptionally well,' CEO says
Fierce Pharma
Thu, 02/27/25 - 09:16 pm
Madrigal Pharmaceuticals
Rezdiffra
MASH
Madrigal Pharmaceuticals enrols patients in Phase III trial of NASH cirrhosis drug
Clinical Trials Arena
Tue, 10/22/24 - 11:29 am
Madrigal Pharmaceuticals
Rezdiffra
NASH
clinical trials
How Madrigal plans to win on the market with the first MASH drug
Pharma Voice
Thu, 10/10/24 - 09:51 am
Madrigal Pharmaceuticals
MASH
Rezdiffra
Madrigal's Rezdiffra off to strong start, but 'bumpiness' is coming: analyst
Fierce Pharma
Thu, 08/8/24 - 11:15 am
Madrigal Pharmaceuticals
Rezdiffra
MASH
‘Remarkable interest’: Madrigal touts early launch progress for first MASH drug Rezdiffra despite VA hurdle
Fierce Pharma
Tue, 05/7/24 - 06:28 pm
Madrigal Pharmaceuticals
Rezdiffra
MASH
NASH
5 Promising MASH Therapies That Could Follow Madrigal’s Rezdiffra
BioSpace
Mon, 04/15/24 - 11:24 am
MASH
NASH
Madrigal Pharmaceuticals
Rezdiffra
Ionis Pharmaceuticals
ION224
Altimmune
pemvidutid
89Bio
pegozafermin
Viking Therapeutics
VK2809
Aligos Therapeutics
ALG-055009
Madrigal’s Rezdiffra Energizes MASH Space, Sets Bar for Future Therapies
BioSpace
Mon, 03/18/24 - 11:25 am
Madrigal Pharmaceuticals
Rezdiffra
NASH
MASH
Madrigal wins FDA approval of first drug for MASH
BioPharma Dive
Thu, 03/14/24 - 06:27 pm
Madrigal Pharmaceuticals
FDA
Rezdiffra
MASH
NASH